| 000 | 01090 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514131504.0 | ||
| 264 | 0 | _c19981101 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTALLEY, R W | |
| 245 | 0 | 0 |
_aComparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation. _h[electronic resource] |
| 260 |
_bCancer _cApr 1963 |
||
| 300 |
_a440-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnatomy |
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 | _aBreast Neoplasms |
| 650 | 0 | 4 | _aFluoxymesterone |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethyltestosterone |
| 700 | 1 | _aBRENNAN, M J | |
| 700 | 1 | _aVAITKEVICIUS, V K | |
| 700 | 1 | _aBECKETT, V L | |
| 773 | 0 |
_tCancer _gvol. 16 _gp. 440-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g _zAvailable from publisher's website |
| 999 |
_c13750455 _d13750455 |
||